The s-APEX1 levels of the HCC, CC, and ccRCC groups were between the levels of the healthy control group and the HBV DNA (+) group and showed sufficient diagnostic accuracy to distinguish between the healthy control and the HBV DNA (+) group. This evidence concerns the gene APEX1 and cholangiocarcinoma.